Fulgent Genetics
FLGT
75 hedge funds and large institutions have $138M invested in Fulgent Genetics in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 18 closing their positions.
22% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 18
3% more funds holding
Funds holding: 73 → 75 (+2)
0.6% more ownership
Funds ownership: 59.08% → 59.69% (+0.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
14% less capital invested
Capital invested by funds: $160M → $138M (-$22M)
42% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$3.71M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$3.41M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$3.36M |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$1.93M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OWIM
Old West Investment Management
Los Angeles,
California
|
-$2.61M |
| 2 |
RJT
Raymond James Trust
St. Petersburg,
Florida
|
-$1.15M |
| 3 |
Renaissance Technologies
New York
|
-$1.07M |
| 4 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$1.02M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.01M |
FLGT Hedge Fund Activity: Q1 2020 in Review
75 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q1 2020, worth a combined $138M — down 14% from $160M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new FLGT positions and 18 closed out — a net gain of 4 holders — while 15 added to existing stakes and 26 trimmed.
The largest buyer was Ranger Investment Management, adding an estimated $3.71M. The largest seller was Old West Investment Management, cutting an estimated $2.61M.
- 75 institutional investors held Fulgent Genetics (FLGT) as of Q1 2020, up from 73 in Q4 2019.
- Funds reported $138M of Fulgent Genetics stock for Q1 2020, down 14% quarter-over-quarter.
- 22 funds opened new Fulgent Genetics positions in Q1 2020 and 18 closed out, a net change of +4 holders.
- The largest Fulgent Genetics buyer in Q1 2020 was Ranger Investment Management, an estimated $3.71M added.
- The largest Fulgent Genetics seller in Q1 2020 was Old West Investment Management, an estimated $2.61M sold.
Based on aggregated 13F filings for Q1 2020.